Robert L. Jones has a broad corporate law practice devoted to the representation of technology companies, and particularly companies in the life sciences industries. His practice includes the full range of corporate and securities law matters, including public and private financings, advice regarding disclosure issues and securities law compliance and fiduciary issues. Previously, he served as the firm's business department chair and chair of the firm's life sciences practice.

Download full bio 


  • Cytokinetics – $450 Million Convertible Senior Notes Offering 

  • Portola Agrees to Sell to Alexion for $1.41 Billion 

  • Cell Design Labs Sells to Gilead 

  • Cell Design Labs: Collaboration Agreement with Kite Pharma and Simultaneous Series of Private Financings 

  • Exelixis and Ipsen Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Regions Outside the United States, Canada and Japan 

  • View all


  • Stanford Law School
    JD, Order of the Coif, 1979

  • Stanford University
    MBA, Henry Ford II Scholar, 1979

  • Swarthmore College
    BA, Economics

Admissions & Credentials



  • American Bar Association

Rankings & Accolades

    Chambers USA: Life Sciences – Corporate/ Commercial (2007 – 2021)

    Best Lawyers in America: Lawyer of the Year – Biotechnology and Life Sciences (2021)

    Legal 500: Healthcare & Life Sciences (2011– 2016)

    Northern California Super Lawyer (since 2004)